# Efficacy of Ciclesonide on Small Airways in Patients With Stable Asthma (18 to 60 y) (BY9010/M1-131)

> **NCT00163345** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 20 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Ciclesonide

## Key facts

- **NCT ID:** NCT00163345
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2006-05
- **Final completion:** 2006-05
- **Target enrollment:** 20 (—)
- **Last updated:** 2016-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00163345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00163345, "Efficacy of Ciclesonide on Small Airways in Patients With Stable Asthma (18 to 60 y) (BY9010/M1-131)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00163345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*